Fundraising Fox
Kiniksa
NASDAQ: KNSAHamilton · Founded 2015 · 412 employees on LinkedIn · 3 known investors
Find your way into Kiniksa
Sign up to see every warm intro you have to Kiniksa
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kiniksa team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.
Founders & leadership
Board
Investors · 3
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$276.9M disclosed across 4 rounds · 2015–2019
▶$8.8MraisedNov 2020 · 10 investors · BiotechnologyRule 506(b)
- RICHARD S LEVYDirector
- STEPHEN R BIGGARDirector
- FELIX J BAKERDirector
- THOMAS W BEETHAMExecutive Officer
- SANJ K PATELExecutive Officer, Director
- THOMAS R MALLEYDirector
- G. BRADLY COLEDirector
- BARRY D QUARTDirector
- KIMBERLY J POPOVITSDirector
- TRACEY L MCCAINDirector
- Offering amount
- $8.8M
- Amount sold
- $8.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Bermuda, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 1
Companies working in the same space as Kiniksa.
Frequently asked questions
- What does Kiniksa do?
- Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.
- Who are Kiniksa's investors?
- Kiniksa's investors include Sofinnova Ventures, Deerfield Management Company, Sofinnova Venture Partners.
- How much funding has Kiniksa raised?
- Kiniksa has disclosed $276.9M raised across 4 rounds.
- Where is Kiniksa headquartered?
- Kiniksa is headquartered in Hamilton.